Tesofensine In Patients with Obesity 5

Trial Profile

Tesofensine In Patients with Obesity 5

Phase of Trial: Phase II/III

Latest Information Update: 08 Jun 2009

At a glance

  • Drugs Amfetamine; Tesofensine
  • Indications Obesity
  • Focus Pharmacodynamics
  • Acronyms TIPO-5
  • Sponsors NeuroSearch
  • Most Recent Events

    • 08 Jun 2009 NeuroSearch successfully completes End of Phase II meeting with the US FDA.
    • 26 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top